Rapid Communication
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 21, 2006; 12(43): 7038-7041
Published online Nov 21, 2006. doi: 10.3748/wjg.v12.i43.7038
Table 1 Comparison of serum and biliary biochemical constituents among three groups (mean ± SD, n = 21)
GroupTBIL (μmol/L)DBIL (μmol/L)ALT (nkat/L)γ-GT (nkat/L)TBA (μmol/L)
Serum
Cholestasis188.76 ± 72.88bd130.76 ± 48.18bd126.80 ± 82.12b266.20 ± 92.73bd118.62 ± 43.58b
Hepatitis125.91 ± 64.2868.67 ± 36.75b96.11 ± 53.69b140.57 ± 70.32a111.89 ± 51.54b
Control124.89 ± 62.076.19 ± 2.5524.23 ± 7.1779.06 ± 35.2514.50 ± 9.76
Biliary
Cholestasis78.13 ± 58.86b52.63 ± 42.43b8.07 ± 4.21167.00 ± 100.06b180.05 ± 216.98b
Hepatitis89.95 ± 59.12b63.56 ± 53.39b8.21 ± 4.15278.55 ± 201.10b 266.63 ± 268.09b
Control252.36 ± 108.81174.08 ± 92.567.22 ± 3.41783.50 ± 363.28643.63 ± 80.67
Table 2 Comparison of serum and biliary IL-6 and TNF-α among three groups (mean ± SD, n =21, ng/L)
GroupSerum IL-6Serum TNF-αBiliary IL-6Biliary TNF-α
Cholestasis63.76 ± 26.67bd493.11 ± 137.26bd286.92 ± 102.02bdf1625.89 ± 563.41bdf
Hepatitis40.81 ± 19.32b305.30 ± 94.45b 183.64 ± 76.94bf1068.55 ± 383.35bf
Control11.46 ± 6.54214.32 ± 78.4040.11 ± 19.89535.80 ± 168.69